Impact Proteomics
Biotechnology ResearchUnited States2-10 Employees
Impact Proteomics is an immune-profiling biotech company that enables known and novel antigen discovery leveraging a unique and unbiased platform. We empower scientists across academia and industry with data that can be used to develop new therapeutics and accelerate the diagnosis, prognosis, and treatment of diseases such as autoimmune and cancer. In addition to our proprietary discovery platform, we also provide proteomic and multiomic (protein, DNA, RNA, metabolites) sample preparation products and services.